Himachal Pradesh to organize National Pharma Summit in September

To help the pharmaceutical companies located in Baddi and in Solan district of Himachal Pradesh (HP) to better their performances further, the Baddi Barotiwala Nalagarh Development Authority (BBNDA), under the Government of HP, will organize a National Pharma Summit in September in which all stakeholders of the Indian pharmaceutical sector and government officials of the nearby states will be invited.

The event was earlier decided to be conducted in the first week of next month in Chandigarh for the convenience of participants and industry doyens from all states, but due to some government programmes scheduled in the week, the pharma summit has been postponed to a further date which will be announced very shortly, sources informed Pharmabiz.

According to sources, the government has decided to shore up the capabilities of the pharma industries and brush up the skill of the company staffs and to increase the quality of the medicines manufactured in the state by providing all kinds of incentives and technical support to the manufacturers because several units have already closed down their production and some of them have shifted to other states like Jharkhand and Sikkim due to unfeasible conditions in HP.

In the Pharma Summit, the BBNDA will try to bring industry leaders from almost all the states, government officials including Central and state regulators, pharma researchers, academia and healthcare professionals from various states. The summit will discuss the latest trends, challenges and opportunities in the pharmaceutical sector, especially in Himachal, and provide a platform to foster collaboration and partnerships for promoting pharmaceutical advancements in the northern part of the country. The event will consist of keynote addresses, panel discussions, interactive sessions, networking opportunities and a programme of knowledge sharing. The manufacturers of pharma and medical devices will showcase their latest products and services in the summit.

Sharing information with Pharmabiz, sources said the topics for discussions include emerging trends in pharma R&D, overcoming regulatory challenges, advancements in drug discovery and delivery systems, harnessing artificial intelligence and big data in pharma, promoting innovation and collaboration, addressing healthcare disparities through accessible and affordable medicines, role of digital health technologies in transforming pharma landscape, quality assurance and GMP, supply chain optimization and sustainability, impact of IPR on pharma innovation, enhancing pharmacovigilance and drug safety monitoring, promoting ethical practices and compliance in the pharma industry sector.

It is learnt that the organizers have invited the additional chief secretary in-charge of health department in Jharkhand state, Dr. Arun Kumar Singh, as the chief speaker in the inaugural session of the programme. He is expected to speak for collaboration between the two states in promoting the pharma sector in the northern part of the country.

The Joint drug controller of Jharkhand, Sumar Kumar Tiwari said the National Pharma Summit 2023 to be organized by the Government of Himachal Pradesh is supported by the health department of Jharkhand and several pharma manufacturers and regulatory officials from Ranchi will attend the event. He said the pharma industry sector in Jharkhand is also planning to organize one pharma event in Ranchi. According to him, the upcoming 500 acre pharma park in Fuddi in Jharkhand is in the pipeline and the government of the state has already decided to provide all kinds of incentives and tax holidays to the entrepreneurs who want to open their units in the pharma park.

Tiwari had earlier submitted a comprehensive proposal to the Government of Jharkhand for the setting up of the pharma park which is set up 18 kilometers away from the Ranchi airport. The industry in the state hopes that Jharkhand will become a major pharma hub in the eastern part of the country to support the pharmaceutical needs of the eastern and the north-eastern states.

Source : 1